You are here » Home » Companies » Company Overview » Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd.

BSE: 531633 Sector: Health care
NSE: LINCOLN ISIN Code: INE405C01035
BSE 00:00 | 18 Jun 300.75 -17.50
(-5.50%)
OPEN

318.60

HIGH

324.00

LOW

282.00

NSE 00:00 | 18 Jun 310.95 -7.40
(-2.32%)
OPEN

322.35

HIGH

324.90

LOW

303.10

OPEN 318.60
PREVIOUS CLOSE 318.25
VOLUME 23051
52-Week high 338.85
52-Week low 154.20
P/E 9.96
Mkt Cap.(Rs cr) 602
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 318.60
CLOSE 318.25
VOLUME 23051
52-Week high 338.85
52-Week low 154.20
P/E 9.96
Mkt Cap.(Rs cr) 602
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Lincoln Pharmaceuticals Ltd. (LINCOLN) - Company History

Lincoln Pharmaceuticals promoted by Mahendra G Patel Rajnikant G Patel and Hasmukhbhai I Patel as a partnership firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a public limited company in Jan. '95. All the assets and business of the erstwhile partnership was transferred to the company. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda Gujarat for manufacturing tablets capsules liquid and powder syrups and ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district) Gujarat to manufacture small volume parenterals like dry powder injectables liquid vial liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project.In 2000-01 the company has been granted ISO 9002 certificate and WHO registration.